Dr. Ni Nyoman Sri Budayanti as a member of the OHCC Udayana representative revealed that the results of the study also showed an increase in immunity of more than 90 percent of at least three types of antibiotics tested 11. The three types of antibiotics are ampicillin, amoxicillin and erythromycin. Whereas for nalidixic acid, an antibiotic that is often used to treat urinary tract infections in humans, there has been an increase in immunity up to 50 percent.
The problem is that these antibiotics are the most widely used antibiotics in the community and can often be purchased without a prescription.
"The most worrying thing about the results of the study is that 2.4 percent of E. coli bacteria are resistant to cephalosporin antibiotics. These bacteria will produce enzymes that can neutralize all cephalosporin group antibiotics," said Ni Nyoman Sri Budayanti.
Cephalosporin antibiotics are the most used antibiotics in hospitals in Indonesia. These bacteria that have been resistant to antibiotics will generally easily trigger immunity to other antibiotics such as the quinolone class antibiotic (ciprofloxacin, levofloxacin) which is one of the main antibiotics for the treatment of patients who are hospitalized.
The discovery of multi-resistant bacteria in broiler chicken sold in traditional or modern markets according to Ni Nyoman certainly raises anxiety because these bacteria can move to humans during the process of handling chicken meat for consumption.
It is possible that humans will be infected by multi-resistant bacteria from the chicken meat.
The consumption of the Indonesian people towards broiler chickens or broiler chicken which are sold daily in traditional or modern markets is unusually high. However, almost escaped the attention of the threat that threatens behind the pleasure of consuming chickens which are on average harvested at the age of 45-50 days.
The condition of increasing immunity to antibiotics is known as Antimicrobial Resistance (AMR). Currently AMR is a serious threat in the health sector throughout the world, including in Indonesia. Patients infected with multiresistant bacteria will complicate treatment because there are currently not many new antibiotics in the world.
A further consequence is that patient care costs increase because longer treatment times and the types of antibiotics used will be more expensive and often require a combination of several antibiotics to treat the infection.
Likewise the mortality rate will increase because sometimes there are no more antibiotics that can be used. These bacteria are often also not sensitive to one type of antibiotic, but these antibiotics are not available in Indonesia.
The treatment of patients infected with multi-resistant bacteria is not only a burden on individuals but the state will also bear the burden through the claims of BPJS which currently continues to lose.
It takes serious commitment from the government because in dealing with AMR not only once but must be sustainable. The decisive action is to regulate the use of antibiotics for the growth of livestock.
If not addressed immediately, the impact will be antimicrobial resistance in humans and the adverse effects will also be sustained, "said the lead researcher, Prof. Dr. Wiku Adisasmito, PhD, MSc who is also Chairman of the Board of Professors of FKM UI and Indonesian Coordinator of One Health University Network (INDOHUN )
No comments:
Post a Comment